Legal Opinion
Dey Pharma, LP v. SUNOVION PHARMACEUTICALS INC.
Court of Appeals for the Federal Circuit
Decided April 16, 2012No. 2011-1507PublishedCited by 9 opinions
1Opinion of the Court
DYK, Circuit Judge.
Dey Pharma, LP and Dey Inc. (“Dey”) brought suit against Sunovion Pharmaceuticals, Inc. (“Sunovion”) seeking a declaratory judgment that Dey’s generic pharmaceutical product does not infringe Sunovion’s U.S. Patent No. 6,451,289 (“the '289 patent”), and that the '289 patent is invalid. The district court concluded that it had subject-matter jurisdiction over the action, and the parties thereafter stipulated to a final judgment of noninfringement. See Dey Pharma, L.P. v. Sunovion Pharms. Inc., No. 08-372 (D.Del. June 20, 2011) (final judgment); Dey LP v. Sepracor Inc., No.…
2Cases cited14 opinions
- Friends of the Earth, Inc. v. Laidlaw Environmental Services (TOC), Inc.Supreme Court of the United States · 2000
- Maryland Casualty Co. v. Pacific Coal & Oil Co.Supreme Court of the United States · 1941
- Arizonans for Official English v. ArizonaSupreme Court of the United States · 1997
- MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
- Preiser v. NewkirkSupreme Court of the United States · 1975
9 more not listed; retrieve them via the Exa API.
3Cited by9 opinions
- Alcon Research, Ltd. v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2014
- Celgene Corporation v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2021
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- Stoneeagle Services, Inc. v. GillmanCourt of Appeals for the Federal Circuit · 2014
- Abbvie Inc. v. Medimmune LimitedCourt of Appeals for the Federal Circuit · 2018
4 more not listed; retrieve them via the Exa API.